reviewOncogeneOct 20, 2003Closed access

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

Fox Chase Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

817
total citations
FWCI
16.78
Percentile
100%
References
63
Citations per year

Authors

1

Topics & keywords

Keywords
  • Rituximab
  • CD20
  • Monoclonal antibody
  • Lymphoma
  • Immunology
  • Follicular lymphoma
  • Cancer research
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.